These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 7907097

  • 41. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR, BOLDER II Study Group.
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [Abstract] [Full Text] [Related]

  • 42. A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder.
    Cutler NR, Hesselink JM, Sramek JJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 May; 18(3):447-63. PubMed ID: 7915845
    [Abstract] [Full Text] [Related]

  • 43. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
    Feltner D, Hill C, Lenderking W, Williams V, Morlock R.
    J Psychiatr Res; 2009 Oct; 43(15):1224-30. PubMed ID: 19423131
    [Abstract] [Full Text] [Related]

  • 44. Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study.
    Merideth C, Cutler AJ, She F, Eriksson H.
    Int Clin Psychopharmacol; 2012 Jan; 27(1):40-54. PubMed ID: 22045039
    [Abstract] [Full Text] [Related]

  • 45. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
    Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN.
    Depress Anxiety; 2008 Jan; 25(7):E1-11. PubMed ID: 17587217
    [Abstract] [Full Text] [Related]

  • 46. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM, Brion S, Escande M, Ropert R, Sacquepee L, Singer L, Scotto JC.
    Encephale; 1984 Jan; 10(3):135-8. PubMed ID: 6389091
    [Abstract] [Full Text] [Related]

  • 47. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder.
    Ballenger JC, McDonald S, Noyes R, Rickels K, Woods SW, Patin J, Lydiard B, Garvey M, Cook B, Goodard AW.
    Adv Biochem Psychopharmacol; 1992 Jan; 47():431-47. PubMed ID: 1354920
    [No Abstract] [Full Text] [Related]

  • 48. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT, Clary CM.
    Compr Psychiatry; 2003 Jan; 44(5):360-9. PubMed ID: 14505296
    [Abstract] [Full Text] [Related]

  • 49. [alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo].
    Hantouche EG, Guelfi JD, Comet D.
    Encephale; 1998 Jan; 24(5):469-79. PubMed ID: 9850822
    [Abstract] [Full Text] [Related]

  • 50. Effectiveness of bedtime dosing of benzodiazepines: a placebo-controlled comparison of halazepam and clorazepate.
    Aden GC, O'Hair DE.
    Clin Ther; 1980 Jan; 3(3):209-18. PubMed ID: 6109568
    [Abstract] [Full Text] [Related]

  • 51. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 52. Early response and 8-week treatment outcome in GAD.
    Rynn M, Khalid-Khan S, Garcia-Espana JF, Etemad B, Rickels K.
    Depress Anxiety; 2006 Nov; 23(8):461-5. PubMed ID: 16845651
    [Abstract] [Full Text] [Related]

  • 53. Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.
    Petracca A, Nisita C, McNair D, Melis G, Guerani G, Cassano GB.
    J Clin Psychiatry; 1990 Sep; 51 Suppl():31-9. PubMed ID: 2211564
    [Abstract] [Full Text] [Related]

  • 54. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
    Zung WW, Daniel JT, King RE, Moore DT.
    J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
    [Abstract] [Full Text] [Related]

  • 55. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B, Saletu-Zyhlarz G, Anderer P, Brandstätter N, Frey R, Gruber G, Klösch G, Mandl M, Grünberger J, Linzmayer L.
    Neuropsychobiology; 1997 Jul; 36(3):130-52. PubMed ID: 9313245
    [Abstract] [Full Text] [Related]

  • 56. Buspirone and diazepam in anxiety: a controlled study.
    Rickels K, Weisman K, Norstad N, Singer M, Stoltz D, Brown A, Danton J.
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):81-6. PubMed ID: 6130078
    [Abstract] [Full Text] [Related]

  • 57. Buspirone in the management of major depression: a placebo-controlled comparison.
    Fabre LF.
    J Clin Psychiatry; 1990 Sep; 51 Suppl():55-61. PubMed ID: 2211570
    [Abstract] [Full Text] [Related]

  • 58. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
    Stokes DK.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769
    [Abstract] [Full Text] [Related]

  • 59. Estazolam treatment of insomnia in generalized anxiety disorder: a placebo-controlled study.
    Post GL, Patrick RO, Crowder JE, Houston J, Ferguson JM, Bielski RJ, Bailey L, Pearlman HG, Shu VS, Pierce MW.
    J Clin Psychopharmacol; 1991 Aug; 11(4):249-53. PubMed ID: 1918423
    [Abstract] [Full Text] [Related]

  • 60. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R, Annable L, Chouinard G, Ogilvie RI.
    J Clin Psychopharmacol; 1983 Apr; 3(2):80-7. PubMed ID: 6132936
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.